summaryrefslogtreecommitdiff
path: root/derivation_to_json/before.json
diff options
context:
space:
mode:
authorPatrick Simianer <p@simianer.de>2015-11-11 16:10:58 +0100
committerPatrick Simianer <p@simianer.de>2015-11-11 16:10:58 +0100
commit25674bcbde962f6fc27448af147b88b853a168f7 (patch)
tree4e95781a163c7790a10bb3a1af0982c2d42a7a89 /derivation_to_json/before.json
parentfbf4cb550ebdcefc4552167e5c6938a5fce2b86d (diff)
extract rules from post-edit alignment
Diffstat (limited to 'derivation_to_json/before.json')
-rw-r--r--derivation_to_json/before.json127
1 files changed, 127 insertions, 0 deletions
diff --git a/derivation_to_json/before.json b/derivation_to_json/before.json
new file mode 100644
index 0000000..1d2c911
--- /dev/null
+++ b/derivation_to_json/before.json
@@ -0,0 +1,127 @@
+{
+ "phrase_alignment": [
+ [
+ 1
+ ],
+ [
+ 2,
+ 0
+ ],
+ [
+ 3
+ ],
+ [
+ 4
+ ],
+ [
+ 5
+ ],
+ [
+ 6
+ ],
+ [
+ 7
+ ],
+ [
+ 8
+ ],
+ [
+ 9
+ ],
+ [
+ 10
+ ],
+ [
+ 11
+ ],
+ [
+ 12
+ ],
+ [
+ 13
+ ],
+ [
+ 14
+ ]
+ ],
+ "source_rgroups": [
+ 4,
+ 3,
+ 7,
+ 6,
+ 5,
+ 8,
+ 9,
+ 11,
+ 12,
+ 13,
+ 10,
+ 9,
+ 8,
+ 14
+ ],
+ "target_rgroups": [
+ 3,
+ 4,
+ 3,
+ 7,
+ 6,
+ 5,
+ 8,
+ 9,
+ 11,
+ 12,
+ 13,
+ 10,
+ 9,
+ 8,
+ 14
+ ],
+ "rules_by_span_id": {
+ "4": "[X] ||| weiterhin gehört ||| also ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=0.458975 MaxLexFgivenE=4.79441 CountEF=0.30103 SampleCountF=0.477121 EgivenFCoherent=0.30103 ||| 0-0 1-0\n",
+ "3": "[X] ||| [X] zur Erfindung [X] ||| the invention [X] relates to [X] ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=0 MaxLexEgivenF=3.63316 MaxLexFgivenE=1.80404 CountEF=0.30103 SampleCountF=1.27875 EgivenFCoherent=1.25527 ||| 1-4 2-3\n",
+ "7": "[X] ||| die Verwendung dieser Zusammensetzungen zur ||| the use of said compositions for the ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=2.93053 MaxLexFgivenE=3.26928 CountEF=0.30103 SampleCountF=0.69897 EgivenFCoherent=0.60206 ||| 0-0 1-1 2-3 3-4 4-5\n",
+ "6": "[X] ||| [X] Therapie und Prophylaxe von ||| [X] therapy and prophylaxis of ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.926982 MaxLexFgivenE=1.42237 CountEF=0.90309 SampleCountF=1.47712 EgivenFCoherent=0.6173 ||| 1-1 2-2 3-3 4-4\n",
+ "5": "[X] ||| [X] Herz-Kreislauf-Erkrankungen ||| [X] cardiovascular diseases ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.739399 MaxLexFgivenE=0.797149 CountEF=1.38021 SampleCountF=1.69897 EgivenFCoherent=0.328468 ||| 1-1 1-2\n",
+ "8": "[X] ||| , Erkrankungen [X] Krebserkrankungen [X] ||| , diseases [X] cancerous diseases [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.3856 MaxLexFgivenE=0.862494 CountEF=0.477121 SampleCountF=0.778151 EgivenFCoherent=0.39794 ||| 0-0 1-1 3-3 3-4\n",
+ "9": "[X] ||| im Zusammenhang [X] oder ||| in conjunction [X] or ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.43987 MaxLexFgivenE=2.45332 CountEF=0.778151 SampleCountF=1.44716 EgivenFCoherent=0.732394 ||| 0-0 1-1 3-3\n",
+ "11": "[X] ||| mit einer erhöhten [X] ||| with an increased [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.72017 MaxLexFgivenE=2.04771 CountEF=0.954243 SampleCountF=1.6902 EgivenFCoherent=0.778151 ||| 0-0 1-1 2-2\n",
+ "12": "[X] ||| Thrombozytenaggregation , [X] ||| platelet aggregation [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.886057 MaxLexFgivenE=1.98654 CountEF=0.477121 SampleCountF=0.69897 EgivenFCoherent=0.30103 ||| 0-0 0-1\n",
+ "13": "[X] ||| Stoffwechsel-Erkrankungen ||| asdf ||| ForceRule=1 ||| 0-0\n",
+ "10": "[X] ||| [X] , Knochenerkrankungen ||| [X] , osteopathy ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=1.11792 MaxLexFgivenE=0.186321 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 1-1 2-2\n",
+ "14": "[X] ||| . ||| . ||| IsSupportedOnline=1 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.0201086 MaxLexFgivenE=0.135104 CountEF=2.39967 SampleCountF=2.48287 EgivenFCoherent=0.0835026 ||| 0-0\n"
+ },
+ "source_groups": [
+ "weiterhin gehört",
+ "zur Erfindung",
+ "die Verwendung dieser Zusammensetzungen zur",
+ "Therapie und Prophylaxe von",
+ "Herz-Kreislauf-Erkrankungen",
+ ", Erkrankungen",
+ "im Zusammenhang",
+ "mit einer erhöhten",
+ "Thrombozytenaggregation ,",
+ "Stoffwechsel-Erkrankungen",
+ ", Knochenerkrankungen",
+ "oder",
+ "Krebserkrankungen",
+ "."
+ ],
+ "target_groups": [
+ "the invention",
+ "also",
+ "relates to",
+ "the use of said compositions for the",
+ "therapy and prophylaxis of",
+ "cardiovascular diseases",
+ ", diseases",
+ "in conjunction",
+ "with an increased",
+ "platelet aggregation",
+ "asdf",
+ ", osteopathy",
+ "or",
+ "cancerous diseases",
+ "."
+ ]
+}